Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4R06

Crystal Structure of SR2067 bound to PPARgamma

Summary for 4R06
Entry DOI10.2210/pdb4r06/pdb
DescriptorPeroxisome proliferator-activated receptor gamma, 1-(naphthalen-1-ylsulfonyl)-N-[(1S)-1-phenylpropyl]-1H-indole-5-carboxamide, SULFATE ION, ... (4 entities in total)
Functional Keywordsnuclear receptor, ligand binding protein, transcription
Biological sourceHomo sapiens (human)
Cellular locationNucleus: P37231
Total number of polymer chains2
Total formula weight62981.10
Authors
Marrewijk, L.,Kamenecka, T.,Griffin, P.R.,Bruning, J.B. (deposition date: 2014-07-30, release date: 2016-01-27, Last modification date: 2023-09-20)
Primary citationvan Marrewijk, L.M.,Polyak, S.W.,Hijnen, M.,Kuruvilla, D.,Chang, M.R.,Shin, Y.,Kamenecka, T.M.,Griffin, P.R.,Bruning, J.B.
SR2067 Reveals a Unique Kinetic and Structural Signature for PPAR gamma Partial Agonism.
Acs Chem.Biol., 11:273-283, 2016
Cited by
PubMed Abstract: Synthetic full agonists of PPARγ have been prescribed for the treatment of diabetes due to their ability to regulate glucose homeostasis and insulin sensitization. While the use of full agonists of PPARγ has been hampered due to severe side effects, partial agonists have shown promise due to their decreased incidence of such side effects in preclinical models. No kinetic information has been forthcoming in regard to the mechanism of full versus partial agonism of PPARγ to date. Here, we describe the discovery of a partial agonist, SR2067. A co-crystal structure obtained at 2.2 Å resolution demonstrates that interactions with the β-sheet are driven exclusively via hydrophobic interactions mediated through a naphthalene group, an observation that is unique from other partial agonists. Surface plasmon resonance revealed that SR2067 binds to the receptor with higher affinity (KD = 513 nM) as compared to that of full agonist rosiglitazone, yet it has a much slower off rate compared to that of rosiglitazone.
PubMed: 26579553
DOI: 10.1021/acschembio.5b00580
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.22 Å)
Structure validation

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon